Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemiaStéphane Picard, François‐Xavier Mahon|Blood|2006Cited by 604
MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line modelsFrançois‐Xavier Mahon, Junia V. Melo|Blood|2003Cited by 538
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid LeukemiaClaude Preudhomme, François Guilhot, Franck E. Nicolini et al.|New England Journal of Medicine|2010Cited by 385
Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cellsKelly Airiau, François‐Xavier Mahon|Oncotarget|2015Cited by 21